Topic About Facet-Biotech---Overview | diod.biz

Facet Biotech Product and Clinical Trials Pipeline

Posted on 5 February 2012 | 11:44 pm

Status Indication Name(s) Phase Trial Name Identification; Active: Relapsing Remitting Multiple Sclerosis >Interferon β 1a >DAC HYP: Phase_III: Efficacy and Safety

Read More : Facet Biotech Product and Clinical Trials Pipeline